30 closest matches · ranked by relevance
Stage II Peripheral Arterial Occlusive Disease · Intermittent Claudication Fontaine Stage II PAOD
Primary: Ratio of Pain-free Walking Distance After Period 2 in Comparison With the Findings at Baseline — 2.60; 1.98 meter/meter
Peripheral Artery Disease
Primary: Exercise Tolerance Assessed by Measuring Distance (m) Walked in 6-minutes — 388.75; 414.96; 404.29; 419.73 meters
Intermittent Claudication · Peripheral Vascular Disease
Primary: Change From Baseline in Initial Walking Distance — 64.3 metres
Peripheral Arterial Disease · Intermittent Claudication
Primary: Tolerability Test - Related Withdrawals — 1; 3 Participants
Peripheral Arterial Disease
Primary: Walking Endurance — -14; 35 Meters
Peripheral Arterial Disease · Hypertension · Diabetes
Primary: Total Walking Distance — 618; 572 meter — p=<0.05
Intermittent Claudicants
Primary: Maximum Walking Distance (MWD). — 137; 143 Metres
Peripheral Arterial Disease · Intermittent Claudication
Primary: Change in Absolute Claudication Distance (ACD) in Meters From Baseline — -16.8; -6.7; 76.2; -0.9 metres
Peripheral Arterial Disease
Primary: Absolute Claudication Distance (ACD) — 54.374; 0.792 Meters
Intermittent Claudication · Peripheral Vascular Disease · Lower Limb Arterial Disease
Primary: Initial Walking Distance Measured by Treadmill — 65.60; 95.50 metres
Intermittent Claudication · Peripheral Vascular Diseases
Primary: Difference in the Absolute Walking Distance (AWD) at 3 Months Between the Two Treatment Groups — 220.12; 242.97; 327.74; 370.38 Meters — p=0.28
Peripheral Vascular Disease · Intermittent Claudication
Primary: Maximum Walking Distances — 147; 68 Meters
Coronary Heart Disease
Primary: Brachial Flow Velocity — 21.0 cm/sec
Peripheral Artery Disease (PAD); Intermittent Claudication
Primary: Number of Participants With Adverse Events (AEs), Drug-related AEs, Serious Adverse Events (SAEs) and Deaths — 18; 17; 4; 4 Participants
Peripheral Artery Disease
Primary: Six-minute Walk Distance — -6.4; 34.5; -15.1 meters
Critical Limb Ischemia
Primary: To Determine Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor in Patients With CLI. — 173; 140; 71; 63 P2Y12 reaction units…
Arterial Occlusive Disease · Intermittent Claudication · Insulin Resistance
Primary: Lower Extremity Skeletal Muscle Glucose Uptake — 62.9; 48.6; 49.5 umol/kg/min
Spinal Stenosis
Primary: Mean Percentage Change in Symptom Severity at 6 Weeks Compared to Baseline, Using the Patient Completed Zurich Claudication Questionnaire for Symptom Severity — -29.7…
Peripheral Artery Disease · Intermittent Claudication
Primary: Peak Walking Time (PWT) — 2.2; 1.2 minutes — p=0.238
Intermittent Claudication
Primary: Change in Peak Walking Time (PWT) From Baseline — 5.394; 5.712; 1.121; 1.493 minutes — p=0.727
Venous Thrombosis · Deep Vein Thrombosis
Primary: Rate of Deep Vein Thrombosis — 14; 15; 9; 12 participants — p=0.785
Chronic Limb Threatening Ischemia
Primary: EuroQoL-5D Visual Acuity Scale (VAS) Score — 47.55; 69.15; 65.35 score on a scale — p=0.005
Spinal Stenosis
Primary: Mean Percentage Change From Baseline in Physical Function at 1 Year Follow-up Using the Patient Completed Zurich Claudication Questionnaire — -32.31; -37.48 percentage…
Critical Limb Ischemia
Primary: Asses the Prevalence of High On-treatment Platelet Reactivity in Critical Limb Ischemia Patients Treated With Aspirin and Clopidogrel. — 18; 17; 8; 57 Participants
Critical Lower Limb Ischemia
Primary: Late Lumen Loss (LLL) of the Target Lesion by Quantitative Vascular Angiography (QVA) — 0.605; 0.616 mm
Peripheral Arterial Disease · Intermittent Claudication
Primary: Modified Physical Performance Test — 31.8; 32.3 scores on a scale
Peripheral Artery Disease
Primary: Composite of Major Adverse Events (MAE) Defined as the Occurrence of In-hospital Myocardial Infarction (MI) or Target Segment Revascularization, Target Limb Loss, or…
Peripheral Artery Disease
Primary: Changes in Walking Distance After Three-months Intervention — 289.68; 262.95 meters
Critical Limb Ischemia
Primary: Reintervention, Above Ankle Amputation and Restenosis (RAS) — 7; 4 Participants
Lymphedema
Primary: Median Time to Wound Closure at 9 Months — 141; 211 median number of days for complete heali